Large gap with delayed quotes
|
Last quote
09/03/2025
-
17:43:29
|
Bid
09/03/2025 -
17:43:47
|
Bid Volume |
Ask
09/03/2025 -
17:43:47
|
Ask Volume |
|---|---|---|---|---|
|
17.22
-0.63
(
-3.53% )
|
17.22
|
1,800 |
17.23
|
1,200 |
Analysis date: 02.09.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 22.04.2025.
Interest
Strong
Strong
Three stars since 08.08.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 25.03.2025 at a price of 10.51.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 08.08.2025.
4wk Rel Perf
26.60%
26.60%
The four-week dividend-adjusted overperformance versus SP500 is 26.60%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.94%.
Mkt Cap in $bn
9.12
9.12
With a market capitalization >$8bn, ELANCO ANIMAL HEALTH is considered a large-cap stock.
G/PE Ratio
0.87
0.87
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
15.01
15.01
The estimated PE is for the year 2027.
LT Growth
13.02%
13.02%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
120
120
For 1% of index variation, the stock varies on average by 1.20%.
Correlation
0.48
0.48
48.30% of stock movements are explained by index variations.
Value at Risk
4.28
4.28
The value at risk is estimated at USD 4.28. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
08.01.2019
08.01.2019